Printer Friendly

Sanko Junyaku Patents Its Proprietary Gene Amplification Method PALSAR in EU.

Tokyo, Japan, Sept 12, 2005 - (JCNN) - Sanko Junyaku announced on September 12 that its proprietary gene amplification method was officially patented in the EU as of September 7.

Numbered 1002877 in the Patent Gazette, the patented method named Probe Alternation Link Self-Assembly Reaction (PALSAR), uses two DNA probes that cover three complementary areas to amplify genetic signals by repeating hybridization. No nucleic-acid synthesizing enzyme is needed for hybridization.

The PALSAR method can react in a short time (30 seconds to 30 minutes) at a constant temperature (40 to 70 degrees centigrade). It can detect targeted DNA and RNA highly accurately.

The method is expected to be used in a wide range of applications including medicine, food, environment, agriculture and stockbreeding. Currently, Sanko Junyaku's subsidiary Palma Bee'Z Research Institute is working on research on PALSAR with a view to commercializing diagnostic agents for infectious diseases.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Sep 13, 2005
Words:160
Previous Article:TOTO Verifies Anti-cancer Property of Photocatalytic Titanium Dioxide Particle.
Next Article:MediBIC, Kazusa DNA Research Institute to Collaborate in New Drug Development.


Related Articles
VYSIS SHIPS GENOSENSOR MICROARRAY SYSTEM FOR GENOMIC RESEARCH.
ENZO BIOCHEM GETS NEW PATENT ALLOWANCES IN U.S/CANADA.
ONLINE PROGRAM ACCELERATES MEDICAL RESEARCH PROGRAMS.
Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs.
Use molecular tools to determine ability of probiotics to hinder pathogens.
Enzo Life Sciences Launches New Advanced Amplification Technology for Gene Expression Analysis Studies.
Sysmex to Introduce New Analyzer for Detecting Breast Cancer Lymph-Node Metastasis to European Market.
Sanko Junyaku, Eisai and Fujirebio Sign Joint Research Agreement for Development of New KL-6 Test Kit.
Enzo Biochem Acquires License to Six Key RNA Amplification Patents.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters